Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis

被引：0
|
作者：
Xiangyu Kong
Yiqi Du
Guokun Wang
Jun Gao
Yanfang Gong
Lei Li
Zhuo Zhang
Jiaqi Zhu
Qing Jing
Yongwen Qin
Zhaoshen Li
机构：
[1] Second Military Medical University,Department of Gastroenterology, Changhai Hospital
[2] Second Military Medical University,Department of Cardiology, Changhai Hospital
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
Pancreatic cancer; Serum microRNA; Biomarker; miR-196a;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：602 / 609
页数：7
相关论文
共 50 条
  • [31] Serum p53 antibodies as a prognostic marker in patients with pancreatic ductal adenocarcinoma (PDAC)
    Zhang, Xibo
    Shang, Haitao
    Li, Zhonglian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (08): : 8376 - 8381
  • [32] Postoperative Serum Albumin Level is a Marker of Incomplete Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
    Matsumoto, Ippei
    Tanaka, Masaki
    Shirakawa, Sachiyo
    Shinzeki, Makoto
    Toyama, Hirochika
    Asari, Sadaki
    Goto, Tadahiro
    Yamashita, Hironori
    Ishida, Jun
    Ajiki, Tetsuo
    Fukumoto, Takumi
    Shimokawa, Mototsugu
    Ku, Yonson
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (07) : 2408 - 2415
  • [33] Postoperative Serum Albumin Level is a Marker of Incomplete Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
    Ippei Matsumoto
    Masaki Tanaka
    Sachiyo Shirakawa
    Makoto Shinzeki
    Hirochika Toyama
    Sadaki Asari
    Tadahiro Goto
    Hironori Yamashita
    Jun Ishida
    Tetsuo Ajiki
    Takumi Fukumoto
    Mototsugu Shimokawa
    Yonson Ku
    Annals of Surgical Oncology, 2015, 22 : 2408 - 2415
  • [34] GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma
    Yang, Sen
    Zhang, Yalu
    Hua, Yuze
    Cui, Ming
    Wang, Mengyi
    Gao, Junyi
    Liu, Qiaofei
    Liao, Quan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer
    Hua, Yongqiang
    Chen, Hao
    Wang, Libing
    Wang, Feng
    Wang, Peng
    Ning, Zhouyu
    Li, Ye
    Liu, Luming
    Chen, Zhen
    Meng, Zhiqiang
    CANCER BIOMARKERS, 2017, 20 (01) : 95 - 100
  • [36] High serum miR-203 predicts the poor prognosis in patients with pancreatic cancer
    Ma, Jun
    Li, Xiaokun
    Huang, Qingxing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (04): : 4688 - 4693
  • [37] High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
    Maria Cristina Curia
    Fabiana Fantini
    Rossano Lattanzio
    Francesca Tavano
    Francesco Di Mola
    Mauro Piantelli
    Pasquale Battista
    Pierluigi Di Sebastiano
    Alessandro Cama
    BMC Cancer, 19
  • [38] Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
    Zhang, Yalu
    Liu, Qiaofei
    Liu, Jingkai
    Liao, Quan
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [39] High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma
    Yanmiao Huo
    Minwei Yang
    Wei Liu
    Jianyu Yang
    Xueliang Fu
    Dejun Liu
    Jiao Li
    Junfeng Zhang
    Rong Hua
    Yongwei Sun
    Journal of Experimental & Clinical Cancer Research, 34
  • [40] Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma
    Foo, Wai Chin
    Rashid, Asif
    Wang, Hua
    Katz, Matthew H.
    Lee, Jeffrey E.
    Pisters, Peter W.
    Wolff, Robert A.
    Abbruzzese, James L.
    Fleming, Jason B.
    Wang, Huamin
    HUMAN PATHOLOGY, 2013, 44 (06) : 1024 - 1030
12345